These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4143056)

  • 1. Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
    Stühlinger W; Kourilsky O; Kanfer A; Sraer JD
    Lancet; 1974 Sep; 2(7883):788-9. PubMed ID: 4143056
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Serum-complement levels in haemolytic-uraemic syndrome.
    Monnens L; Hendrickx G; van Wieringen P; van Munster P
    Lancet; 1974 Aug; 2(7875):294. PubMed ID: 4135724
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent haemolytic-uraemic syndrome with hypocomplementaemia: a case report.
    Bogdanović R; Cvorić A; Nikolić V; Sindjić M
    Pediatr Nephrol; 1988 Apr; 2(2):236-8. PubMed ID: 3153016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura.
    Cameron JS; Vick R
    Lancet; 1973 Oct; 2(7835):975. PubMed ID: 4795545
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Serum-complement levels in haemolytic-uraemic syndrome.
    Kaplan BS; Thomson PD; MacNab GM
    Lancet; 1973 Dec; 2(7844):1505-6. PubMed ID: 4129358
    [No Abstract]   [Full Text] [Related]  

  • 6. [Persistent activation of C3 in the hemolytic uremic syndrome].
    Gonzalo A; Sarrias J; Alsina J
    Rev Clin Esp; 1977 May; 145(4):281-3. PubMed ID: 866752
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent haemolytic uraemic syndrome and acquired hypomorphic variant of the third component of complement.
    Roodhooft AM; McLean RH; Elst E; Van Acker KJ
    Pediatr Nephrol; 1990 Nov; 4(6):597-9. PubMed ID: 2088459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement system in hemolytic-uremic syndrome in childhood.
    Monnens L; Molenaar J; Lambert PH; Proesmans W; van Munster P
    Clin Nephrol; 1980 Apr; 13(4):168-71. PubMed ID: 7379368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in thrombotic microangiopathy.
    Karpman D; Tati R
    Hamostaseologie; 2013 May; 33(2):96-104. PubMed ID: 23411690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible C1q bypass loop activation in the haemolytic uraemic syndrome.
    Nolin L; O'Regan S; Pelletier M; Rivard GE; Mongeau JG; Robitaille P
    Clin Exp Immunol; 1979 Jan; 35(1):107-11. PubMed ID: 371879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3 in the involved renal tissue.
    Gonzalo A; Mampaso F; Gallego N; Bellas C; Segui J; Ortuño J
    Clin Nephrol; 1981 Oct; 16(4):193-9. PubMed ID: 7028337
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement activation is associated with more severe course of diarrhea-associated hemolytic uremic syndrome, a preliminary study.
    Karnisova L; Hradsky O; Blahova K; Fencl F; Dolezel Z; Zaoral T; Zieg J
    Eur J Pediatr; 2018 Dec; 177(12):1837-1844. PubMed ID: 30251107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli-associated paediatric haemolytic uraemic syndrome.
    Ahlenstiel-Grunow T; Hachmeister S; Bange FC; Wehling C; Kirschfink M; Bergmann C; Pape L
    Nephrol Dial Transplant; 2016 Jul; 31(7):1114-21. PubMed ID: 27190382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemolytic-uremic syndrome, low C-3 and positive ANCA].
    Castellano I; Pereira LF; Gómez-Martino JR; Covarsí A
    Nefrologia; 2006; 26(1):146-7. PubMed ID: 16649441
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement evaluation in atypical hemolytic uremic syndrome: current concepts.
    Sethi SK; Jhaveri KD
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1074-6. PubMed ID: 22982929
    [No Abstract]   [Full Text] [Related]  

  • 16. Adult hemolytic uremic syndrome with renal arteriolar deposition of IgM andC3.
    Hammar SP; Bloomer HA; McCloskey D
    Am J Clin Pathol; 1978 Sep; 70(3):434-9. PubMed ID: 152058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome.
    Ferraris JR; Ferraris V; Acquier AB; Sorroche PB; Saez MS; Ginaca A; Mendez CF
    Clin Exp Immunol; 2015 Jul; 181(1):118-25. PubMed ID: 25677399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic uremic syndrome with hypocomplementemia, serum C3NeF, and glomerular deposits of C3.
    Barré P; Kaplan BS; de Chadarévian JP; Drummond KN
    Arch Pathol Lab Med; 1977 Jul; 101(7):357-61. PubMed ID: 577389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does dysregulated complement activation contribute to haemolytic uraemic syndrome secondary to Streptococcus pneumoniae?
    Gilbert RD; Nagra A; Haq MR
    Med Hypotheses; 2013 Sep; 81(3):400-3. PubMed ID: 23786906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.